The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis

Modern Rheumatology

Volumn 19, Issue 3, 2009, Pages 302-308

  Takahashi, Akitaka ^a   Mori, Masaaki ^a   Naruto, Takuya ^a   Nakajima, Shoko ^a   Miyamae, Takako ^a   Imagawa, Tomoyuki ^a   Yokota, Shumpei ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cytokines; Differential diagnosis; Heme oxygenase 1 (HO 1); Systemic idiopathic juvenile arthritis (s JIA)

Indexed keywords

AMYLOID A PROTEIN; BETA 2 MICROGLOBULIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; FERRITIN; FIBRIN DEGRADATION PRODUCT; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADOLESCENT; AORTITIS; ARTICLE; CHILD; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC ONSET JUVENILE RHEUMATOID ARTHRITIS;

ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; FEMALE; HEME OXYGENASE-1; HUMANS; MALE; ROC CURVE;

EID: 67349268535     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0152-6     Document Type: Article

References (37)

1. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517-54.
2. Tsuchihashi S, Fondevia C, Kupiec-Weglinski JW. Heme oxygenase system in ischemia and reperfusion injury. Ann Transplant. 2004;9:84-7.
3. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme Oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003;24:449-55.
4. Katori M, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 system in organ transplantation. Transplantation. 2002;74:905-12.
5. Otterbein LE, Choi AM. Heme oxygenase: Colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol. 2000;279:1029-37.
6. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, Loop T, et al. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem. 2003;278:36993-8.
7. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422-8.
8. Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, Soares MP. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-κB to protect endothelial cells from tumor necrosis factor-α-mediated apoptosis. J Biol Chem. 2002;277:17950-61.
9. Inoue S, Suzuki M, Nagashima Y, Suzuki S, Hashiba T, Tsuburai T, et al. Transfer of heme oxygenase-1 cDNA by a replication- deficient adenovirus enhances interleukin-10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther. 2001;12:967-79.
10. Hashiba T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Tsuburai T, et al. Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther. 2001;8:1499-507.
11. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001;89:168-73.
12. Tsuchihashi S, Livhits M, Zhai Y, Busuttil RW, Araujo JA, Kupiec-Weglinski JW. Basal Rather Than Induced Heme Oxygenase-1 Levels Are Crucial in the Antioxidant Cytoprotection. J Immunol. 2006;177:4749-57.
13. Tsui TY, Wu X, Lau CK, Ho DW, Xu T, Siu YT, et al. Prevention of chronic deterioration of heart allograft by recombinant adeno- associated virus-mediated heme oxygenase-1 gene transfer. Circulation. 2003;107:2623-9.
14. Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop- Bailey D, Inoue K, et al. 15-deoxy-Δ12, 14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest. 2000;106:189-97.
15. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8:240-6.
16. Cssidy JT, Petty RE. Textbook of pediatric rheumatology, 5th edn. Philadelphia: W. B. Saunders; 2005.
17. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: Possible relationship to drugs or infection. J Pediatr. 1985;106:561-6.
18. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85:421-6.
19. Imagawa T, Katakura S, Mori M, Aihara Y, Mitsuda T, Yokota S. A case of macrophage activation syndrome developed with systemic juvenile rheumatoid arthritis. Ryumachi. 1997;37:487-92.
20. Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: Characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6 and TNF-α-producing macrophages. Blood. 2005;105:1648-51.
21. Kirino Y, Takeno M, Iwasaki M, Ueda A, Ohno S, Shirai A, et al. Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: Use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther. 2005;7:616-24.
22. Ravelli A, Silvia MM, Angela P, Cristina B, Tiziana F, Nicolino R, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr. 2005;146:598-604.
23. Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immunol. 2006;6:410-5.
24. Yokota S. Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis. Curr Opin Rheumatol. 2003;15:581-6.
25. Deshane J, Wright M, Agarwal A. Heme oxygenase-1 expression in desease states. Acta Biochim Pol. 2005;52:273-84.
26. Takahashi T, Morita K, Akagi R, Sassa S. Heme-Oxygenase-1: A novel therapeutic target in oxidative tissue injuries. Curr Med Chem. 2004;11:1545-61.
27. Kirino Y, Takeno M, Murakami S, Kobayashi M, Kobayashi H, Miura K, et al. Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis Rheum. 2007;2:464-75.
28. Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr. 2003;3:363-7.
29. Morimoto K, Ohta K, Yachie A, Yang Y, Shimizu M, Goto C, et al. Cytoprotective role of heme oxygenase-1 in human kidney with various renal disease. Kidney Int. 2001;60:1858-66.
30. Yang Y, Ohta K, Shimizu M, Morimoto K, Goto C, Nakai A, et al. Selective protection of renal tubular epithelial cells by heme oxygenase-1 during stress-induced injury. Kidney Int. 2003;64:1302-9.
31. Ohta K, Yachie A, Fujimoto K, Kaneda H, Wada T, Toma T, et al. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J kidney Dis. 2000;35:868-70.
32. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103:129-35.
33. Alam J, Camhi S, Choi AM. Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. J Biol Chem. 1995;270:11977-84.
34. Wasserman WW, Fahl WE. Functional antioxidant responsive elements. Proc Natl Acad Sci USA. 1997;94:5361-6.
35. Kashiwagi Y, Kawashima H, Nishimata S, Nagao R, Watanabe K, Takekuma K, et al. Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome. Clin Rheumatol. 2008;27:277-9.
36. Janssen R, Verhard E, Lankester A, Ten Cate R, van Dissel JT. Enhanced interleukin-1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum. 2004;50:3329-33.
37. Mizuno K, Toma T, Tsukiji H, Okamoto H, Yamazaki H, Ohta K, et al. Selective expansion of CD16 high CCR2- subpopulation of circulating monocytes with preferential production of haem oxygenase-1 in response to acute inflammation. Clin Exp Immunol. 2005;142:461-70.